Envista Holdings (NVST) Shares Outstanding (Diluted Average) (2017 - 2026)
Envista Holdings (NVST) recorded quarterly Shares Outstanding (Diluted Average) of $166.4 million in Q2 2026, down 1.65% quarter-over-quarter from $169.2 million in Q4 2025, and down 4.15% on a YoY basis from $173.6 million in Q2 2025.
Envista Holdings (NVST) Shares Outstanding (Diluted Average) (2017 - 2026) Analysis & Trends
Envista Holdings' Shares Outstanding (Diluted Average) history runs 10 years deep, the most recent figure standing at $166.4 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Diluted Average) fell 4.15% year-over-year to $166.4 million; the TTM figure through Apr 2026 stood at $166.4 million (down 4.15% YoY), while the FY2025 annual figure was $169.2 million, down 1.74% from the prior year.
- Shares Outstanding (Diluted Average) was $166.4 million for Q2 2026 at Envista Holdings, down from $169.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $179.8 million in Q2 2022 to a low of $166.4 million in Q2 2026.
- Historically, Shares Outstanding (Diluted Average) has averaged $173.6 million across 5 years, with a median of $173.4 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) fell 6.02% in 2023, then grew 3.18% in 2024.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $177.6 million in 2022, then dropped by 6.02% to $166.9 million in 2023, then advanced by 3.18% to $172.2 million in 2024, then declined by 1.74% to $169.2 million in 2025, then dropped by 1.65% to $166.4 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $166.4 million (Q2 2026), $169.2 million (Q4 2025), and $170.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 147.79 Bn | 143.40 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.23 Bn | 40.22 Bn | 2.15 Bn | - |
| 3 | Medline | 30.57 Bn | 36.41 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 28.04 Bn | 26.38 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 23.76 Bn | 23.24 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.40 Bn | 13.40 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Cooper Companies | 13.18 Bn | 13.04 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Align Technology | 12.72 Bn | 11.66 Bn | 736.59 Mn | 71.61 Mn |
| 9 | Baxter International | 10.71 Bn | 8.67 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Envista Holdings | 4.04 Bn | 2.96 Bn | 390.10 Mn | 166.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 166.40 Mn |
| Dec 31, 2025 | 169.20 Mn |
| Sep 26, 2025 | 170.30 Mn |
| Jun 27, 2025 | 171.70 Mn |
| Mar 28, 2025 | 173.60 Mn |
| Dec 31, 2024 | 172.20 Mn |
| Sep 27, 2024 | 172.10 Mn |
| Jun 28, 2024 | 172.00 Mn |
| Mar 29, 2024 | 173.40 Mn |
| Dec 31, 2023 | 166.90 Mn |
| Sep 29, 2023 | 175.20 Mn |
| Jun 30, 2023 | 176.30 Mn |
| Mar 31, 2023 | 177.40 Mn |
| Dec 31, 2022 | 177.60 Mn |
| Sep 30, 2022 | 178.40 Mn |
| Jul 1, 2022 | 179.20 Mn |
| Apr 1, 2022 | 179.80 Mn |
| Dec 31, 2021 | 177.60 Mn |
| Oct 1, 2021 | 178.10 Mn |
| Jul 2, 2021 | 177.20 Mn |